TERN - Wall Street Estimates - Terns Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 3.475

-5.83 %

$ 295 M

Market Cap

-2.94

P/E

Price Target Average

439.57%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

29.81%

Net Income Estimate

--4.63%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Terns Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for TERN of $18.8 , with forecasts ranging from a low of $10 to a high of $26 .

TERN Lowest Price Target Wall Street Target

10 USD 187.77%

TERN Average Price Target Wall Street Target

18.8 USD 439.57%

TERN Highest Price Target Wall Street Target

26 USD 648.20%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free